LifeLabs Buys Centogene's Canadian Genetic Testing Business | GenomeWeb

NEW YORK (GenomeWeb News) – LifeLabs Medical Laboratory Services today announced it has acquired the Canadian business of Centogene for an undisclosed amount.

Germany-based Centogene provides genetic testing for inherited diseases and performs testing for a number of genetic centers in Canada. During the next few months, Centogene's test portfolio will be transitioned to Toronto-based LifeLabs, and Centogene's services will continue uninterrupted to clients in Canada, LifeLabs said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.